Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence

The tissue engineering market is poised for significant growth, projected to expand from USD 15.01 billion in 2026 to USD 27.59 billion by 2031, with a compound annual growth rate (CAGR) of 12.95%. This surge is largely driven by advancements in regenerative medicine and the increasing demand for innovative solutions to repair or replace damaged tissues and organs. The rising prevalence of chronic diseases, trauma-related injuries, and age-associated conditions further fuels this growth, as healthcare providers and researchers adopt tissue engineering methodologies to meet clinical needs and enhance patient outcomes.

The implications of these findings are profound, as the market is witnessing a shift towards engineered tissues and scaffolds that can alleviate the reliance on organ transplants, addressing critical donor shortages. Key applications in this domain include orthopedics, skin regeneration, cardiovascular repair, and dental restoration. Technological innovations in biomaterials, 3D bioprinting, and stem cell technologies are crucial in developing functional tissue constructs, which are becoming increasingly viable for clinical applications. Moreover, strategic collaborations between academic institutions and biotechnology companies are amplifying research and development efforts, further solidifying the market’s trajectory.

A significant takeaway for professionals in the field is the emergence of Asia-Pacific as a high-growth region, driven by expanding healthcare infrastructure and increasing investments in biotechnology. This trend suggests a potential shift in research and development hubs, as countries like China, India, and Japan enhance their focus on regenerative medicine. The sustained growth in the tissue engineering market not only highlights the evolving clinical landscape but also underscores the importance of integrating advanced technologies to improve patient-specific treatment options, ultimately reshaping therapeutic approaches in longevity and healthspan research.

Source: globenewswire.com